Low-dose subcutaneous ketamine infusion and morphine tolerance
- PMID: 10506678
- DOI: 10.1016/s0304-3959(99)00096-2
Low-dose subcutaneous ketamine infusion and morphine tolerance
Abstract
The NMDA receptor has been reported to be involved in opioid tolerance. Adjuvant subcutaneous infusion treatment with (very) low-dose ketamine, a NMDA receptor antagonist, improves analgesia and at the same time appears to reduce morphine tolerance. Three cases are presented.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical